Connection

Yuri Peterson to HEK293 Cells

This is a "connection" page, showing publications Yuri Peterson has written about HEK293 Cells.
Connection Strength

0.286
  1. Development of inhibitors of heterotrimeric Gai subunits. Bioorg Med Chem. 2014 Jul 01; 22(13):3423-34.
    View in: PubMed
    Score: 0.106
  2. Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. J Med Chem. 2018 03 22; 61(6):2589-2603.
    View in: PubMed
    Score: 0.035
  3. Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Nat Commun. 2017 11 16; 8(1):1534.
    View in: PubMed
    Score: 0.034
  4. Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia. J Med Chem. 2016 11 10; 59(21):9942-9959.
    View in: PubMed
    Score: 0.032
  5. The conformational signature of ?-arrestin2 predicts its trafficking and signalling functions. Nature. 2016 Mar 31; 531(7596):665-8.
    View in: PubMed
    Score: 0.030
  6. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013 Jun 28; 288(26):18872-84.
    View in: PubMed
    Score: 0.025
  7. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol. 2013; 522:229-62.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.